Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-18-006503
Filing Date
2018-02-16
Accepted
2018-02-16 08:50:04
Documents
1
Period of Report
2018-02-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6889
  Complete submission text file 0001127602-18-006503.txt   8188
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MAHON PAUL A (Reporting) CIK: 0001231589 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 18619762